Amphastar Unit Receives US FDA Warning Letter on Violations at California Facility
() -- Amphastar Pharmaceuticals (AMPH) unit International Medication Systems has received a warning letter from the US Food and Drug Administration on violations at its drug manufacturing facility in South El Monte, California, Amphastar said in a regulatory filing Wednesday. The letter received on July 2 cited violati